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Animal models for CP in rats can be classiﬁed into 2 groups: one is noninvasive or nonsurgical models and the other is invasive
or surgical models. Pancreatic injury induced by repetitive injections of supramaximal stimulatory dose of caerulein (Cn) or
by intraductal infusion of sodium taurocholate (NaTc) recovered within 14 days, whereas that caused by repetitive injection
of arginine or by intraductal infusion of oleic acid was persistent. However, the destroyed acinar tissues were replaced by fatty
tissues without ﬁbrosis. Transient stasis of pancreatic ﬂuid ﬂow by 0.01% agarose and minimum injury of the pancreatic duct by
0.1% NaTc solution induced progressive pancreatic injury although one alone is insuﬃcient to cause persistent pancreatic injury.
However, the damaged tissue was replaced by fatty tissue without ﬁbrosis. Continuous pancreatic ductal hypertension (PDH)
caused diﬀuse interlobular and intralobular ﬁbrosis closely resembling human CP.
1.Introduction
Chronic pancreatitis (CP) is deﬁned as a progressive inﬂam-
matory disease of the pancreas, characterized by irreversible
morphologic changes and ﬁbrotic replacement of the gland.
Epidemiological studies have indicated that chronic alcohol
abuse is a major cause of CP. The second common cause of
chronic pancreatitis is idiopathic, and the third is recurrent
or relapsing pancreatitis due to gallstones [1]. However, the
pathophysiology of CP remains poorly deﬁned. Therefore,
appropriate therapies are still limited, and prognosis has not
improved to date, due mainly to the lack of a satisfactory
animal model for CP.
Animal models for CP in rats can be classiﬁed into 2
groups; one is noninvasive or nonsurgical models such as
chronic ingestion of ethanol and injections of supramaximal
stimulatory doses of caerulein (Cn) or toxic substance, and
the other is invasive or surgical models such as manipulation
of the pancreatic duct or infusion of some toxic substances
into the pancreatic duct. Long-term ethanol feeding alone
is unable to induce acute or chronic pancreatitis in animals
[2, 3]. In addition, CP occurs in only a limited number
of heavy drinkers [4–6]. Since these ﬁndings suggest that
alcohol is a very weak inducer of CP and other factors are
necessary for the onset of the disease, we reviewed animal




2.1. Caerulein-Induced Pancreatitis. Subcutaneous (sc) or
intraperitoneal (ip) injections of supramaximal stimulatory
doses of Cn (20–50μg/kg body weight) in rats induce a
signiﬁcant increase in serum amylase activity and histolog-
ical evidence of acute interstitial pancreatitis. Remarkable
interstitial edema and cytoplasmic vacuoles in acinar cells
are the earliest histological alterations. Cellular inﬁltration
is prominent at 9–12h after the ﬁrst Cn injection. However,
these histological changes almost completely disappear after
24h [9]. Intraperitoneal injections of 20μg/kg body weight
Cn in rats, 4 times at hourly intervals, also induce acute
pancreatitis. Although recurrent attacks of acute pancreatitis
are supposed to be a possible mechanism of CP [10],
repeated attacks of Cn-induced pancreatitis for 5 times at
weekly intervals were unable to induce CP in rats [11].
Yamaguchi et al. [11] revealed that repetitive injections of2 Gastroenterology Research and Practice
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Figure 1: Representative photomicrographs of the pancreas after intraperitoneal (ip) injection of 20μg/kg body weight of Cn (a) or
500mg/100g body weight of arginine (b). (a) Seven days after the last Cn injection (on day 35 after the ﬁrst Cn injection), the pancreas
was recovered and histologically normal. (b) On day 28 after the last ip injection of arginine (on day 40 after the ﬁrst arginine injection),
acinar architecture was destroyed with focal acinar cell necrosis. Inset: on day 42 after the last ip injection of arginine (on day 54 after the
ﬁrst arginine injection), acinar tissues were replaced by fatty tissue. (Hematoxylin and eosin staining, original magniﬁcation ×25).
Cn cause mild damage of the pancreas parenchyma with
inﬂammatory cell inﬁltration on day 29 after the ﬁrst IP Cn
injection (1 day after the last Cn). On day 7 after the last
Cn injection (35 days after the ﬁrst Cn injection), however,
the epithelium of the pancreatic ductules has recovered from
damage, and the pancreas appeared histologically normal
(Figure 1(a)).
2.2. Arginine-Induced Pancreatitis. Tani et al. [12]h a v e
demonstrated that a single ip injection of excessive dose of L-
arginine (500mg/100g body weight) induces the biological
and histological characteristics of acute necrotizing pancre-
atitis in rats. Histological examination revealed degenerative
changes of intracellular organelles and nuclei of acinar cells.
The extent and severity of necrotic changes of pancreatic
exocrine tissue with inﬂammatory cell inﬁltration were
maximal at 72h. Pancreatic acinar cells began to regenerate
within 7 days, and pancreatic architecture appeared almost
normal after 14 days [12]. Delaney et al. [13]h a v er e p o r t e d
that a single ip injection of 500mg/100g body weight of
L-arginine followed by 3 injections of 250mg/100g body
weight over 10 days caused up to 90% acinar destruction
with adipose tissue replacement and undamaged ductal,
vascular,andisletcells.Thesechangeswerepresent6months
after injection. Although this procedure is proposed as a
new, simple, and reproducible method of inducing chronic
pancreatic damage in the rat [13], histological features are
completely diﬀerent from those of CP in humans. Fibrosis
is not found, but the destroyed acinar cells were completely
replaced by adipose tissue. Weaver et al. [14] have shown
that daily ip injections of slightly low dose of arginine
(350mg/100g body weight) for 4 weeks caused progressive
degeneration of the pancreas, and only isolated single acinar
cells were seen within a ﬁbrous connective tissue matrix
contiguous with ducts, blood vessels, intrapancreatic nerves,
and islets. Yamaguchi et al. [11] have demonstrated that ip
injectionsof500mg/100gbodyweightofL-arginine,5times
at 3-day intervals destroyed acinar architecture with focal
acinar cell necrosis. However, on day 7 after the last arginine
injection (on day 22 after the ﬁrst arginine injection),
almost all pancreatic parenchyma are replaced by fatty tissue
(Figure 1(b)). Repetitive ip injections of L-arginine appear
to produce CP similar to that in humans, but histological
appearanceisdiﬀerentfromthatinhumanCP.Inthismodel,
ﬁbrotic tissues are progressively replaced with adipose tissue
with time.
2.3.DibutyltinDichloride-InducedPancreatitis. Merkord and
Hennighausen [15] have shown that a single intravenous (iv)
or ip injection of dibutyltin dichloride (DBTC) causes inter-
stitial pancreatitis, enlargement of diameter, and destruction
of epithelial cells of the bile ducts depending on the dose
of DBTC (1, 4, or 6mg/kg body weight), the route of
administration, and the time after treatment. Single ip
injection of DBTC at a dose of 6mg/kg body weight [16]
or 8mg/kg body weight [17] induced acute interstitial
pancreatitis in rats resulting from toxic necrosis of the
biliopancreatic duct epithelium and obstructing plugs in
the distal common bile duct. Extensive inﬁltration of the
pancreatic interstitium with mononuclear cells was observed
after 7 days followed by the development of ﬁbrosis. Twenty-
eight days after administration of DBTC, one-third of the
rats showed periductal and interstitial ﬁbrosis as well as an
active inﬂammatory process in the pancreas [16]. An active
inﬂammatory process was seen even after 2 months [17].
The presence of chronic inﬂammatory lesions characterized
by the destruction of exocrine parenchyma and ﬁbrosis, and
in the later stages the endocrine parenchyma, indicates CP
[17,18].However,Merkordetal.[16]haverevealedthatonly
one-third of the treated rats show a tendency to a chronic
course, when the obstruction of the duct and cholestasis
persist. Thus, this model cannot be used as an experimental
model of CP because of the uncertainty of reproducibility
and the presence of jaundice.Gastroenterology Research and Practice 3
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Figure 2: Representative photomicrographs of the pancreas after intraductal infusion of 40μL/100g body weight of 3% NaTc solution
(a) or after intraductal infusion of 50μL oleic acid (b). (a-left) On day 7 after intraductal infusion of NaTc, acinar architecture was partially
destroyed,andinﬁltrationofinﬂammatorycellswasobserved.(a-right)Onday14afterintraductalinfusionofNaTc,thepancreasrecovered
withnormalhistological features (Hematoxylin and eosinstaining,originalmagniﬁcation ×25). (b-left)On day 14after intraductalinfusion
of oleic acid, acinar architecture was partially destroyed and replaced by fatty tissue. Tubular complexes were surrounded by fatty tissue. (b-
right) On day 56 after intraductal infusion of oleic acid, almost all pancreatic parenchymal tissues were replaced by fatty tissue, and only islet
cells were observed (Hematoxylin and eosin staining, original magniﬁcation ×25).
3.SurgicalModelof ChronicPancreatitis
3.1. Sodium Taurocholate-Induced Pancreatitis. Aho et al.
[19] have demonstrated that retrograde infusion of sodium
taurocholate (NaTc) into the pancreatic duct system of
the rat causes acute hemorrhagic pancreatitis. The pancre-
atic lesions are immediate and characterized by intersti-
tial edema, extensive necrotic changes of the acinar cells,
and hemorrhages during the ﬁrst 24h after the injec-
tion. The mortality increased depending on the amount
and concentration of the injected NaTc. Marked acinar
atrophy and pancreatic ﬁbrosis are seen in rats surviv-
ing 72h [19]. In contrast, Yamaguchi et al. [11]h a v e
demonstrated that pancreatitis induced by intraductal infu-
sion of 40μL/100g body weight of 3% NaTc solution is
reversible (Figure 2(a)). Partially destructed acinar archi-
tecture and inﬁltration of inﬂammatory cells were seen
from day 3 to day 7 after intraductal infusion of NaTc
(Figure 2(a), left). On day 14, however, the structure of the
pancreatic tissue returned to almost normal (Figure 2(a),
right).
In this model, rats that were infused with a large amount
or high concentration of NaTc solution died, whereas rats
infused with a small amount of NaTc solution at a low
concentration recovered within 14 days. It is diﬃcult to
control the amount and the concentration of NaTc solution
to induce pancreatic ﬁbrosis.
3.2. Oleic Acid-Induced Pancreatitis. Retrograde infusion of
oleic acid [11, 20–23], viscous solution of zein [24], mixture
of zein-oleic acid, or viscous solution consisting of zein-
oleic acid-linoleic acid [25, 26]( 5 0 μL/100g body weight)
into rat pancreatic duct causes severe pancreatic atrophy
with irregular ﬁbrosis and fat replacement over a period of
6 months. Indeed, intraductal infusion of 50μL/rat of oleic
acid destroyed acinar cells and pancreatic ductulus epithelia
and induced inﬁltration of inﬂammatory cells on day 3 [22].
Inﬂammatory cell inﬁltration further increased until day 14
(Figure 2(b), left), but almost all pancreatic parenchymal
cells were replaced by fatty tissues by day 56 (Figure 2(b),
right).Althoughtheseanimalsalsodevelopedmalabsorption
of fat and bentiromide and showed retardation of body
weight in spite of normal food intake [20, 25, 26]; pancreatic
ﬁbrosis was rarely seen except fatty tissues. Kataoka et al.
[26] have proposed that obstructive mechanism in the small
ducts might have played an important role in the genesis
anddevelopmentofCPinthismodel.Retrogradeintraductal
infusion of these substances produced a reproducible and
long-lasting atrophy of the exocrine pancreas with fatty
replacement. These results suggest that viscous substance in
the duct or disturbance of pancreatic ﬂuid ﬂow plays an
important role in the development of persistent damage of
the pancreas.
However, these models of pancreatitis appear quite
diﬀerent from CP in humans. Repetitive injections of Cn or4 Gastroenterology Research and Practice
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Figure 3: Representative photomicrographs of the pancreas after complete ligation of the main pancreatic duct. Common bile duct was
ligated proximal to the pancreas near the liver, and a cannula was inserted above the ligature, and the bile was introduced into the duodenum
via cannula so as to prevent obstructive jaundice. The biliopancreatic duct was completely ligated at its entrance into the duodenum. (a) On
day 7 after the ligation, pancreatic ﬁbrosis was observed only around the slightly dilated duct. (b) On day 14 after the ligation, pancreatic
parenchymal tissues were replaced by fatty tissue without ﬁbrosis. (Hematoxylin and eosin staining, original magniﬁcation ×25).
intraductal infusion of NaTc caused transient pancreatitis,
and the pancreatic injury returned histologically normal
within 14 days. On the other hand, repetitive injection
of arginine or intraductal infusion of oleic acid induced
persistent damage of the pancreas, progressing to pancreatic
insuﬃciency with replacement of almost all pancreatic
parenchymal tissues by fatty tissues without ﬁbrosis. Thus,
histopathological changes in the pancreas of these rats are
diﬀerent from those observed in human CP.
4.CongestionofPancreaticFluidFlow
In the initial lesions of human CP, protein plugs are found
in small pancreatic ducts [7, 27]. In addition, several studies
have shown that the viscosity of pancreatic juice is increased
in patients with CP [28, 29], and that pancreatic ductal
pressure in patients with CP is signiﬁcantly higher than
that in control subjects [30]. Surgical decompression of the
pancreatic duct [31], endoscopic ductal drainage [29, 32], or
removal of intraductal stones by extracorporeal shockwave
lithotripsy (ESWL) improves the clinical outcome of patients
with CP [33]. Taken together, congestion of pancreatic ﬂuid
ﬂow or pancreatic ductal hyperpressure (PDH) seems to
contribute to the pathogenesis of CP. Indeed, obstruction of
the main pancreatic duct by tumors, strictures, or anatomic
variants such as pancreas divisum is another possible cause
of CP [34]. Although these previous studies have demon-
strated that PDH contributes to the pathogenesis of chronic
pancreatitis, complete ligation of the pancreatic duct causes
pancreatic atrophy and fatty degradation rather than ﬁbrosis
(Figure 3).
4.1. Combination of Transient Stasis of Pancreatic Juice Flow
and Mild Pancreatic Duct Injury. Yamaguchi et al. [11]
have reported that pancreatic injury induced by a retro-
grade intraductal infusion of 40μL/100g body weight of
3.0% NaTc solution was transient and returned to normal
within 14 days (Figure 2(a)). On the other hand, previous
studies have suggested the importance of the disturbance
of pancreatic ﬂuid ﬂow for the development of persistent
damage of the pancreas [11, 20–26]. We, therefore, infused
a mixture solution of low-concentration NaTc (0.1%) and
viscous agarose solution (0.01%) to induce mild injury of
the pancreatic duct and a transient stasis of pancreatic ﬂuid
ﬂow. Partial destruction of acinar architecture, inﬁltration of
inﬂammatory cells, and dilatation of pancreatic ducts were
seen on day 7 in rats after intraductal infusion of 40μL/100g
body weight of 0.1% NaTc solution but returned almost
normal structure on day 14 (Figure 4(a)). Mild damage of
the parenchymal tissue with inﬂammatory cell inﬁltration
that was observed on day 7 after intraductal infusion
of 40μL/100g body weight of 0.01% agarose completely
recovered on day 14 (Figure 4(b)). However, intraductal
infusion of a mixture 0.01% agarose and 0.1% NaTc solution
at an amount of 40μL/100g body weight destroyed acinar
architecture with focal acinar cell necrosis and inﬂammatory
cell inﬁltration (Figure 4(c)). Even on day 56, pancreatic
interstitial ﬁbrosis, acinar damage, and dilated pancreatic
ducts were seen. Acinar cell necrosis was surrounded by fatty
tissue. This model of pancreatitis clearly revealed that both
stasis of pancreatic ﬂuid ﬂow and ductal injury are necessary
for the development of persistent injury of the pancreas.
Transient stasis of pancreatic ﬂuid ﬂow and minimum injury
of the pancreatic duct act synergistically to cause progressive
pancreatic injury, although one alone is insuﬃcient to cause
persistent pancreatic injury.
This new model of pancreatitis revealed the importance
of a combination of the disturbance of pancreatic ﬂuid ﬂow
and the injury of pancreatic duct to induce persistent andGastroenterology Research and Practice 5
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Figure 4: Representative photomicrographs of the pancreas after intraductal infusion of 40μL/100g body weight of 0.1% NaTc solution
(a), after intraductal infusion of 40μL of 0.01% agarose (b), or after intraductal infusion of a mixture solution of 0.1% NaTc and 0.01%
agaroseatamountof40μL/100gbodyweight(c).(a)Onday14afterintraductalinfusionof40μL/100gbodyweightof0.1%NaTcsolution,
the pancreas was histologically normal. (b) On day 14 after intraductal infusion of 40μL/100g body weight of 0.01% agarose, the pancreas
appeared almost normal. (c) On day 14 after intraductal infusion of a mixture of 0.01% agarose and 0.1% NaTc solution at an amount of
40μL/100g body weight, acinar architecture was partially destroyed and replaced by fatty tissues. Dilated pancreatic duct with focal acinar



























Figure 5: Schematic diagram of the experimental setup. The height
from the level of the ampulla Vater to the free end of the pancreatic
cannula represents the hydrostatic pressure to the pancreas.
irreversible changes of the pancreas. However, the resulting
histological features are diﬀerent from those of CP in human
because pancreatic ﬁbrosis is rarely seen and pancreatic
parenchyma is replaced by fatty tissue.
5. PancreaticDuctalHypertension
Although PDH contributes to the pathogenesis of CP, com-
plete obstruction of the pancreatic duct results in pancreatic
atrophy and fatty degradation rather than ﬁbrosis (Figure 3).
Yamamoto et al. [35] developed an animal model with PDH
and demonstrated that continuous PDH plays an important
role in the onset and development of CP in rats.
Common bile duct was ligated proximal to the pancreas
near the liver, and a cannula was inserted above the ligature
to collect pure bile. Another cannula was inserted into the
biliopancreatic duct through the ampulla of Vater to collect
pure pancreatic juice. Pancreatic juice and bile were con-
tinuously returned to the duodenum by a servomechanism.
An additional cannula was inserted into the duodenum to
return bilopancreatic juice (Figure 5). During the recovery
and experimental periods, the rat was placed in a modiﬁed
Bollman-type restraint cage and had full access to food and
water ad libitum.
The height from the level of the ampulla Vater to the
free end of the pancreatic cannula represents the hydrostatic
pressure to the pancreas, which was increased to 25cm
by vertically raising the free end of the pancreatic cannula
from the pancreas (Figure 5). The hydrostatic pressure was
raised 5cm each day from 25 to 35cm but not above
35cm to prevent acute pancreatic damage. Pancreatic ductal
pressure was controlled to obtain 25% pancreatic ﬂuid ﬂow
of the control rats that were subjected to the same operative
procedures, but the free end of the pancreatic cannula
was maintained at 4-5cm below the pancreas to maintain
pancreatic ﬂuid ﬂow.
Rats in the PDH group consumed nearly the same
amount of food as those in the control group during the
experimental period, but they failed to gain body weight
and evacuated muddy or soft feces, indicating maldiges-
tion probably due to reduced pancreatic enzyme secretion.
Indeed, amylase and lipase activity in pancreatic ﬂuid
progressively decreased after induction of PDH. Pancreatic
exocrine function evaluated by iv secretin stimulation on
day 14 revealed pancreatic insuﬃciency in the PDH rats.
However, nonenzymatic protein concentration in pancreatic6 Gastroenterology Research and Practice
(a) (b)
(c) (d)
Figure 6: Representative light microscopic appearance of the pancreas in PDH and control groups on day 14 after the induction of PDH. (a)
Pancreatic ﬁbrosis was mainly distributed in the interlobular area with a nodular and lobular pattern. Marked inﬁltration of inﬂammatory
cells was observed mainly in the interlobular area. Inset: representative light microscopic picture of focal fat necrosis. (b) Azan-stained
section showed replacement of normal tissue by fatty and connective tissue. (c) Plug formation in the main pancreatic duct. (d) Minimal
histological changes were observed in the control group on day 14. (Hematoxylin and eosin staining, original magniﬁcation ×25).
ﬂuid gradually increased during continuous PDH after the
initial drop.
Pancreatic ﬁbrosis observed mainly in the intralobular
area and especially in the periductal area on day 7 after the
induction of PDH further progressed and was markedly dis-
tributed in the interlobular or perilobular and intralobular
areas on day 14 (Figures 6(a) and 6(b)). In addition, marked
inﬂammatory cell inﬁltration, predominantly lymphocytes,
was observed in interlobular and intralobular areas. Focal
fat necrosis (Figure 6(a)-inset) and plug formation in the
main pancreatic duct (Figure 6(c)) were also observed on
day 14. These histopathological changes are reliable, repro-
ducible, and closely resemble human CP. The signiﬁcantly
increased concentration of mucoprotein in pancreatic ﬂuid
might have increased the viscosity of pancreatic ﬂuid and
contributed to the formation of protein plugs. In control rats
underwent similar operative procedure but without PDH,
the pancreas showed only minimal histological changes on
day 14 (Figure 6(d)).
Immunoreactivity for type I collagen was markedly
detected around pancreatic ducts and slightly detected in
interlobular and intralobular areas (Figure 7(a)). On the
other hand, collagen type III (Figure 7(b)) and ﬁbronectin
(Figure 7(c)) were markedly detected around the pancreatic
ducts and in interlobular and intralobular areas. Type IV
collagen deposition was observed as irregular and discontin-
uous lines along the basement membrane (BM) of the ducts
(Figure 8(a)), as have been observed in arginine- and oleic
acid-induced pancreatitis [11, 22] and in human CP [36–
38]. In addition, broad deposition of type IV collagen was
observed around the ducts (Figure 8(a)). On the other hand,
in the control rats, type IV collagen deposition was observed
as continuous lines along the BM of the ducts [35], as has
been found in the normal rat [11, 22] and normal human
pancreas [36, 37].
In the PDH rats, α-smooth muscle actin- (α-SMA-)
positive cells, activated pancreatic stellate cells (PSCs), were
observed in periductal, periacinar, and interlobular areas
(Figure 8(b)).However,inthecontrolgroupα-SMA-positive
cells were rarely found except in the vessel walls [35]. PDH
markedly increased the expression level of TGF-β transcript
andwasassociatedwithaprogressiveandsigniﬁcantincrease
in the proportion of the Azan-Mallory blue-stained ﬁbrotic
area (Figure 6(b)). Thus, PDH plays an important role in the
formation of pancreatic ﬁbrosis.
6. Conclusion
Although repetitive injections of arginine or intradauctal
infusion of oleic acid or a mixture of agarose and NaTc
caused persistent pancreatic injury, the damaged tissue
was replaced by fatty tissue without ﬁbrosis. Continuous
PDH caused diﬀuse interlobular and intralobular ﬁbrosis
resembling human CP and resulted in pancreatic exocrine
function with reduced body weight gain and muddy or softGastroenterology Research and Practice 7
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Figure 7: Immunohistochemistry for collagen type I (a), collagen type III (b), and ﬁbronectin (c) in the pancreas on day 14 after the
induction of PDH. (a) Collagen type I was markedly distributed around the pancreatic duct but was slightly distributed in interlobular
and intralobular areas. (b, c) Collagen type III (b) and ﬁbronectin (c) were markedly distributed in interlobular and intralobular areas and
around the pancreatic duct ×100.
(a) (b)
Figure 8: Immunohistochemistry for collagen type IV (a) and α-smooth muscle actin- (α-SMA-) positive cells in the pancreas on day 14
aftertheinductionofPDH.(a)TypeIVcollagendepositionwasobservedasirregularanddiscontinuouslinesalongthebasementmembrane
of the ducts. In addition, broad deposition of type IV collagen was observed around the ducts. (b) α-SMA-positive cells were detected in the
periductal, periacinar, and interstitial areas. Original magniﬁcation ×200.
feces in the presence of unaltered food intake. Therefore,
the PDH model seems suitable for the investigation of the
mechanism of CP. However, there are several limitations
of this animal model; surgical and maintenance skills and
equipmentsarerequiredforthepresentexperimentalmodel.
In addition, it is diﬃcult to maintain this animal model for
more than 3 weeks.
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